We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
LaCroix maker National Beverage Corp. (FIZZ - Free Report) has become a victim of its own success. The company’s sales had soared for years and its stock price came along for the ride, but its flagship flavored seltzer drink became so popular that Coca-Cola (KO - Free Report) , PepsiCo (PEP - Free Report) , and many others flooded the quickly expanding seltzer market.
Lost its Fizz?
National Beverage makes roughly 70% of its sales from LaCroix. The flavored seltzer brand, with multiple flavors, has been around for decades, but really kicked things into high gear over the last five-plus years as consumers searched for alternatives to sugary sodas.
LaCroix began to fly off shelves and helped create the current seltzer drink craze that has slipped over into the alcoholic beverage market, from Anheuser Busch Inbev NV (BUD - Free Report) to Boston Beer (SAM - Free Report) .
National Beverage’s success saw PepsiCo launch its Bubly brand, while Coca-Cola bought Topo Chico in 2017. Coca-Cola is now set to launch its new sparkling water brand AHA in March.
Plus, retail giants such as Target (TGT - Free Report) sell their own store brands and startups are popping up all the time. On top that, the company has been sued in a class-action lawsuit based on claims that its all-natural claims are false. National Beverage has denied the allegations.
In the end, the crowded market makes things harder on National Beverage, and some brands have undercut LaCroix on price. FIZZ still holds the largest market share, based on the most recent industry reports. However, the company’s sales have slipped against hard to compare periods.
Bottom Line
National Beverage’s sales have fallen over the last four quarters, and are down 4.2% in the trailing 12 months. The firm’s earnings have also fallen.
Looking ahead, our Zacks estimates call for the company’s sales to sink 5.1% in its current fiscal year and another 3.1% next year. Worse still, FIZZ is projected to see its adjusted earnings fall over 19% this year and nearly 8% during the next fiscal year.
The nearby chart shows investors just how far FIZZ shares have spilled, down 63% since the fall of 2018. Despite the downturn, National Beverage stock is still trading at 19.7X forward 12-months earnings estimates, which marks a premium compared to the S&P 500’s 18.8X and remains well above its year-long low of 11.7X.
National Beverage has also seen its earnings estimate revision activity trend in the wrong direction recently, which helps it hold a Zack Rank #5 (Strong Sell).
Investors still interested in the broader Beverages market might want to check out #2 (Buy)-ranked Monster Beverage Corporation (MNST - Free Report) or Coca-Cola.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Bear of the Day: National Beverage Corp. (FIZZ)
LaCroix maker National Beverage Corp. (FIZZ - Free Report) has become a victim of its own success. The company’s sales had soared for years and its stock price came along for the ride, but its flagship flavored seltzer drink became so popular that Coca-Cola (KO - Free Report) , PepsiCo (PEP - Free Report) , and many others flooded the quickly expanding seltzer market.
Lost its Fizz?
National Beverage makes roughly 70% of its sales from LaCroix. The flavored seltzer brand, with multiple flavors, has been around for decades, but really kicked things into high gear over the last five-plus years as consumers searched for alternatives to sugary sodas.
LaCroix began to fly off shelves and helped create the current seltzer drink craze that has slipped over into the alcoholic beverage market, from Anheuser Busch Inbev NV (BUD - Free Report) to Boston Beer (SAM - Free Report) .
National Beverage’s success saw PepsiCo launch its Bubly brand, while Coca-Cola bought Topo Chico in 2017. Coca-Cola is now set to launch its new sparkling water brand AHA in March.
Plus, retail giants such as Target (TGT - Free Report) sell their own store brands and startups are popping up all the time. On top that, the company has been sued in a class-action lawsuit based on claims that its all-natural claims are false. National Beverage has denied the allegations.
In the end, the crowded market makes things harder on National Beverage, and some brands have undercut LaCroix on price. FIZZ still holds the largest market share, based on the most recent industry reports. However, the company’s sales have slipped against hard to compare periods.
Bottom Line
National Beverage’s sales have fallen over the last four quarters, and are down 4.2% in the trailing 12 months. The firm’s earnings have also fallen.
Looking ahead, our Zacks estimates call for the company’s sales to sink 5.1% in its current fiscal year and another 3.1% next year. Worse still, FIZZ is projected to see its adjusted earnings fall over 19% this year and nearly 8% during the next fiscal year.
The nearby chart shows investors just how far FIZZ shares have spilled, down 63% since the fall of 2018. Despite the downturn, National Beverage stock is still trading at 19.7X forward 12-months earnings estimates, which marks a premium compared to the S&P 500’s 18.8X and remains well above its year-long low of 11.7X.
National Beverage has also seen its earnings estimate revision activity trend in the wrong direction recently, which helps it hold a Zack Rank #5 (Strong Sell).
Investors still interested in the broader Beverages market might want to check out #2 (Buy)-ranked Monster Beverage Corporation (MNST - Free Report) or Coca-Cola.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>